Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma.

McWilliams RR, Bamlet WR, Rabe KG, Olson JE, de Andrade M, Petersen GM.

Clin Gastroenterol Hepatol. 2006 Sep;4(9):1143-7. Epub 2006 Jul 24.

3.

Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.

Catts ZA, Baig MK, Milewski B, Keywan C, Guarino M, Petrelli N.

Ann Surg Oncol. 2016 May;23(5):1729-35. doi: 10.1245/s10434-015-5026-x. Epub 2016 Jan 4.

PMID:
26727920
4.

Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.

McWilliams RR, Rabe KG, Olswold C, De Andrade M, Petersen GM.

Cancer. 2005 Jul 15;104(2):388-94.

5.
6.

Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patients.

Mizuno S, Nakai Y, Isayama H, Kawahata S, Saito T, Takagi K, Watanabe T, Uchino R, Hamada T, Miyabayashi K, Kogure H, Sasaki T, Yamamoto N, Sasahira N, Hirano K, Tsujino T, Ijichi H, Tateishi K, Tada M, Koike K.

Pancreas. 2014 Oct;43(7):1014-7. doi: 10.1097/MPA.0000000000000158.

PMID:
24979618
7.

Pancreatic cancer patients who smoke and drink are diagnosed at younger ages.

Brand RE, Greer JB, Zolotarevsky E, Brand R, Du H, Simeone D, Zisman A, Gorchow A, Lee SY, Roy HK, Anderson MA.

Clin Gastroenterol Hepatol. 2009 Sep;7(9):1007-12. doi: 10.1016/j.cgh.2009.06.008. Epub 2009 Jun 26.

8.

Pancreatic adenocarcinoma: epidemiology and genetics.

Flanders TY, Foulkes WD.

J Med Genet. 1996 Nov;33(11):889-98. Review.

9.

Family history of pancreatic cancer in a high-risk cancer clinic: implications for risk assessment.

Hall MJ, Dignam JJ, Olopade OI.

J Genet Couns. 2008 Aug;17(4):365-72. doi: 10.1007/s10897-008-9154-3. Epub 2008 Jun 25.

10.

German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.

Rieder H, Sina-Frey M, Ziegler A, Hahn SA, Przypadlo E, Kress R, Gerdes B, Colombo Benkmann M, Eberl T, Grützmann R, Lörken M, Schmidt J, Bartsch DK.

Onkologie. 2002 Jun;25(3):262-6.

PMID:
12119461
11.

Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.

Yeo TP, Hruban RH, Brody J, Brune K, Fitzgerald S, Yeo CJ.

J Gastrointest Surg. 2009 Aug;13(8):1487-94. doi: 10.1007/s11605-009-0923-6. Epub 2009 May 21.

PMID:
19459017
12.

[Hereditary gastric and pancreatic cancer predisposition syndromes].

Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L.

Gastroenterol Hepatol. 2016 Aug-Sep;39(7):481-93. doi: 10.1016/j.gastrohep.2015.11.009. Epub 2016 Feb 23. Review. Spanish.

PMID:
26916701
13.

Familial risk of pancreatic cancer.

Schenk M, Schwartz AG, O'Neal E, Kinnard M, Greenson JK, Fryzek JP, Ying GS, Garabrant DH.

J Natl Cancer Inst. 2001 Apr 18;93(8):640-4.

PMID:
11309441
14.

Evidence for a major gene influencing risk of pancreatic cancer.

Klein AP, Beaty TH, Bailey-Wilson JE, Brune KA, Hruban RH, Petersen GM.

Genet Epidemiol. 2002 Aug;23(2):133-49.

PMID:
12214307
15.

Risk of other cancers in individuals with a family history of pancreas cancer.

Cote ML, Schenk M, Schwartz AG, Vigneau FD, Kinnard M, Greenson JK, Fryzek JP, Ying GS, Garabrant DH.

J Gastrointest Cancer. 2007;38(2-4):119-26. doi: 10.1007/s12029-008-9022-2.

16.

Familial pancreatic cancer.

Rieder H, Bartsch DK.

Fam Cancer. 2004;3(1):69-74. Review.

PMID:
15131409
17.

Clinical and pathologic features of familial pancreatic cancer.

Humphris JL, Johns AL, Simpson SH, Cowley MJ, Pajic M, Chang DK, Nagrial AM, Chin VT, Chantrill LA, Pinese M, Mead RS, Gill AJ, Samra JS, Kench JG, Musgrove EA, Tucker KM, Spigelman AD, Waddell N, Grimmond SM, Biankin AV; Australian Pancreatic Cancer Genome Initiative.

Cancer. 2014 Dec 1;120(23):3669-75. doi: 10.1002/cncr.28863. Epub 2014 Oct 14.

18.

Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study.

Anderson MA, Zolotarevsky E, Cooper KL, Sherman S, Shats O, Whitcomb DC, Lynch HT, Ghiorzo P, Rubinstein WS, Vogel KJ, Sasson AR, Grizzle WE, Ketcham MA, Lee SY, Normolle D, Plonka CM, Mertens AN, Tripon RC, Brand RE.

Am J Gastroenterol. 2012 Nov;107(11):1730-9. doi: 10.1038/ajg.2012.288. Epub 2012 Aug 28.

19.

Elevated cancer mortality in the relatives of patients with pancreatic cancer.

Wang L, Brune KA, Visvanathan K, Laheru D, Herman J, Wolfgang C, Schulick R, Cameron JL, Goggins M, Hruban RH, Klein AP.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2829-34. doi: 10.1158/1055-9965.EPI-09-0557. Epub 2009 Oct 20.

20.

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.

McWilliams RR, Wieben ED, Rabe KG, Pedersen KS, Wu Y, Sicotte H, Petersen GM.

Eur J Hum Genet. 2011 Apr;19(4):472-8. doi: 10.1038/ejhg.2010.198. Epub 2010 Dec 8.

Supplemental Content

Support Center